Rate of serious infections in patients with rheumatoid arthritis receiving tumor necrosis factor (TNF)-alpha antagonist: a prospective observational study

Joint Bone Spine. 2014 Jul;81(4):378-9. doi: 10.1016/j.jbspin.2014.03.020. Epub 2014 Jun 21.

Authors

Rosaria Talarico¹, Chiara Stagnaro, Claudia Ferrari, Pasquale Pepe, Laura Bazzichi, Stefano Bombardieri

Affiliation

¹ Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy. Electronic address: sara.talarico76@gmail.com.

PMID: 24962976
DOI: 10.1016/j.jbspin.2014.03.020

No abstract available

Keywords: Anti-TNF-alpha therapy; Infections; Rheumatoid arthritis.

Publication types

Letter
Comment

MeSH terms

Antirheumatic Agents / adverse effects*
Arthritis, Rheumatoid / drug therapy*
Herpesviridae Infections / etiology*
Humans

Substances

Antirheumatic Agents